Literature DB >> 7317324

Haematological factors associated with proliferative retinopathy in sickle cell-haemoglobin C disease.

R J Hayes, P I Condon, G R Serjeant.   

Abstract

In a selected sample of patients with sickle cell-haemoglobin C (SC) disease, proliferative retinopathy (PSR) occurred in 90/243 (37%) patients, developed most frequently between the ages of 20 and 30 years, and affected 68% patients aged 45 years or over. Comparison of haematological indices in patients with and without PSR, after age-related effects were allowed for, indicated significant relationships with high mean cell volume in males and with low fetal haemoglobin in both sexes. A highly significant relationship with total haemoglobin level in males (as previously reported in SS disease) was shown in SC disease to be entirely secondary to a strong age-related trend in haemoglobin level.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7317324      PMCID: PMC1039644          DOI: 10.1136/bjo.65.10.712

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  Improved rapid methods for the determination of iron content and binding capacity of serum.

Authors:  R N BEALE; J O BOSTROM; R F TAYLOR
Journal:  J Clin Pathol       Date:  1962-03       Impact factor: 3.411

2.  Estimation of small percentages of foetal haemoglobin.

Authors:  K BETKE; H R MARTI; I SCHLICHT
Journal:  Nature       Date:  1959-12-12       Impact factor: 49.962

3.  Factors affecting the rate of coupling of bilirubin and conjugated bilirubin in the van de Bergh reaction.

Authors:  G H LATHE; C R RUTHVEN
Journal:  J Clin Pathol       Date:  1958-03       Impact factor: 3.411

4.  The resistance to blood flow in the capillaries.

Authors:  A W Jay; S Rowlands; L Skibo
Journal:  Can J Physiol Pharmacol       Date:  1972-10       Impact factor: 2.273

5.  Ocular findings in hemoglobin SC disease in Jamaica.

Authors:  P I Condon; G R Serjeant
Journal:  Am J Ophthalmol       Date:  1972-11       Impact factor: 5.258

6.  Ocular findings in homozygous sickle cell anemia in Jamaica.

Authors:  P I Condon; G R Serjeant
Journal:  Am J Ophthalmol       Date:  1972-04       Impact factor: 5.258

7.  Haematological factors associated with proliferative retinopathy in homozygous sickle cell disease.

Authors:  R J Hayes; P I Condon; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1981-01       Impact factor: 4.638

8.  Effect of haematocrit on cerebral blood-flow in man.

Authors:  D J Thomas; J Marshall; R W Russell; G Wetherley-Mein; G H du Boulay; T C Pearson; L Symon; E Zilkha
Journal:  Lancet       Date:  1977-11-05       Impact factor: 79.321

  8 in total
  10 in total

Review 1.  New Ways to Detect Pediatric Sickle Cell Retinopathy: A Comprehensive Review.

Authors:  Daniel A Pahl; Nancy S Green; Monica Bhatia; Royce W S Chen
Journal:  J Pediatr Hematol Oncol       Date:  2017-11       Impact factor: 1.289

2.  Risk factors for proliferative sickle retinopathy.

Authors:  P D Fox; D T Dunn; J S Morris; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1990-03       Impact factor: 4.638

3.  Ocular manifestations in egyptian children and young adults with sickle cell disease.

Authors:  Mona Kamal El-Ghamrawy; Hanan F El Behairy; Amal El Menshawy; Seham A Awad; Ahmed Ismail; Mohamed Salah Gabal
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-23       Impact factor: 0.900

4.  Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.

Authors:  Tiffany T Yu; Julie Nelson; Michael B Streiff; Sophie Lanzkron; Rakhi P Naik
Journal:  Thromb Res       Date:  2016-03-02       Impact factor: 3.944

5.  Concurrent sickle cell hemoglobin C disease and diabetes mellitus: no added risk of proliferative retinopathy?

Authors:  P R Koduri; A R Patel; H A Bernstein
Journal:  J Natl Med Assoc       Date:  1994-09       Impact factor: 1.798

6.  Severe proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia.

Authors:  Clément Lemaire; Yann Lamarre; Nathalie Lemonne; Xavier Waltz; Sadri Chahed; Florence Cabot; Ioana Botez; Benoit Tressieres; Marie-Laure Lalanne-Mistrih; Maryse Etienne-Julan; Philippe Connes
Journal:  Clin Hemorheol Microcirc       Date:  2013-01-01       Impact factor: 2.375

7.  Blood rheology and proliferative retinopathy in sickle cell-haemoglobin C disease.

Authors:  B E Serjeant; K P Mason; P I Condon; R J Hayes; M W Kenny; J Stuart; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

8.  Sickle cell retinopathy in Jamaican children: a search for prognostic factors.

Authors:  J F Talbot; A C Bird; L M Rabb; G H Maude; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1983-11       Impact factor: 4.638

9.  Iris atrophy in sickle cell disease.

Authors:  R W Acheson; S M Ford; G H Maude; R W Lyness; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1986-07       Impact factor: 4.638

Review 10.  Sickle cell disease: new opportunities and challenges in Africa.

Authors:  J Makani; S F Ofori-Acquah; O Nnodu; A Wonkam; K Ohene-Frempong
Journal:  ScientificWorldJournal       Date:  2013-09-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.